Immunitybio Inc
Ownership
Ownership Structure
Who owns Immunitybio Inc (IBRX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 38.4% of the shares are freely tradable; institutional investors hold 17.6%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 3.22 | 34,083,262 | +29.4 | 06/30/2026 |
| State Street Corp | 2.02 | 21,398,438 | +20.8 | 06/30/2026 |
| Vanguard Portfolio Management, LLC | 1.69 | 17,863,911 | +9.4 | 06/30/2026 |
| Vanguard Capital Management, LLC | 1.48 | 15,691,579 | +3.7 | 06/30/2026 |
| D. E. Shaw & Co LP | 1.09 | 11,551,019 | -8.1 | 06/30/2026 |
| Two Sigma Investments LLC | 1.05 | 11,097,106 | +153.0 | 06/30/2026 |
| Geode Capital Management, LLC | 0.93 | 9,847,896 | +22.6 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 1.28 | 13,518,563 | +16.3 | 09/30/2026 |
| State Street® SPDR® S&P® Biotech ETF | 1.11 | 11,778,610 | -1.9 | 09/30/2026 |
| iShares Russell 2000 ETF | 0.94 | 9,991,183 | -1.1 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Simon Barry J. | Director | 2,777,788 | 22,222,304 $ | Oct 5, 2026 | direct |
| Cohen Cheryl | Director | 100,309 | 802,472 $ | Oct 2, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 5, 2026 | Simon Barry J. | Director | Sell | 25,000 | 10.75 | 268,760 |
| Oct 2, 2026 | Cohen Cheryl | Director | Sell | 81,056 | 10.50 | 851,088 |
| Oct 2, 2026 | Cohen Cheryl | Director | Other | 55,979 | 2.98 | 166,817 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.